Profile
John Hunter formerly worked at XOMA Royalty Corp., as Senior Director, Compugen Ltd., as Chief Scientific Officer, Compugen, Inc. (United States), as Vice President-Antibody R&D, Keyhole Therapeutics, Inc., as Chief Executive & Scientific Officer, and FibroGen, Inc., as Chief Scientific Officer from 2021 to 2024.
Dr. Hunter received his undergraduate degree from Hartwick College and doctorate degree from The University of California, San Francisco.
Former positions of John Hunter
| Companies | Position | End |
|---|---|---|
| KYNTRA BIO, INC. | Chief Tech/Sci/R&D Officer | 01/10/2024 |
| XOMA ROYALTY CORPORATION | Director/Board Member | - |
Keyhole Therapeutics, Inc.
Keyhole Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a discovery stage drug company that specializes immunotherapies for cancer and autoimmune diseases | Chief Executive Officer | - |
| COMPUGEN LTD. | Chief Tech/Sci/R&D Officer | - |
Compugen, Inc. (United States) | Corporate Officer/Principal | - |
Training of John Hunter
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Compugen Ltd.
Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
FibroGen, Inc.
FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Hartwick College
Hartwick College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compugen, Inc. (United States) | |
Keyhole Therapeutics, Inc.
Keyhole Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a discovery stage drug company that specializes immunotherapies for cancer and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- John Hunter
















